Electron Transport Chain (Complex I, III, IV) Antibody Sampler Kit #42642
Product Information
Kit Usage Information
Protocols
- 4850: Western Blotting, Immunoprecipitation (Agarose), Immunohistochemistry (Paraffin), Immunofluorescence*, Flow
- 7074: Western Blotting
- 11940: Western Blotting, Immunohistochemistry (Paraffin)
- 24744: Western Blotting
- 55159: Western Blotting
- 70264: Western Blotting, Immunofluorescence
- 71814: Western Blotting
- 95231: Western Blotting
Product Description
The Electron Transport Chain (Complex I, III, IV) Antibody Sampler Kit provides an economical means of detecting select components involved in the electron transport chain (ETC) (Complex I, III, IV). The kit includes enough antibodies to perform two western blot experiments with each primary antibody.
Specificity / Sensitivity
Each antibody in the Electron Transport Chain (Complex I, III, IV) Antibody Sampler Kit detects endogenous levels of its target protein. COX1/MT-CO1 (E2I2R) Rabbit mAb does not cross-react with COX2/MT-CO2 protein or COX3/MT-CO3 protein.
Source / Purification
Monoclonal antibodies are produced by immunizing animals synthetic peptides corresponding to residues surrounding Ile286 of human NDUFS1 protein, Pro72 of human cytochrome c protein, Lys29 of human COX IV protein, Asp31 of human COX10 protein, and near the carboxy terminus of human ACP/NDUFAB1 protein and human COX1/MT-CO1 protein.
Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Pro86 of human UQCRFS1/RISP protein. Antibodies are purified by peptide affinity chromatography.
Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Pro86 of human UQCRFS1/RISP protein. Antibodies are purified by peptide affinity chromatography.
Background
Mitochondrial acyl carrier protein (ACP) is an essential component in fatty acid biosynthesis in mitochondria. It is also known as NADH-ubiquinone oxidoreductase subunit AB1 (NDUFAB1), a Complex I subunit in the electron transport chain (ETC). NDUFAB1 regulates energy and reactive oxygen species (ROS) metabolism in mitochondria by coordinating the assembly of ETC Complexes I, II, and III, and supercomplexes (1). NDUFS1 (NADH dehydrogenase Fe-S protein 1) is a nuclear-encoded structural subunit of NADH: ubiquinone oxidoreductase (Complex I) in the mitochondrial ETC (2). Mutations in NDUFS1 and other Complex I subunits leading to mitochondrial dysfunction are associated with a number of neurological disorders (3-6). Ubiquinol-cytochrome c reductase iron-sulfur subunit (UQCRFS1), also known as Rieske iron-sulfur protein (RISP), is a component of Complex III in the mitochondrial ETC. UQCRFS1/RISP and two other subunits, cytochrome b (MT-CYB) and cytochrome c1 (CYC1), are essential for the catalytic activity of Complex III (7). Cytochrome c is a well conserved electron transport protein and is part of the respiratory chain localized to mitochondrial intermembrane space (8). Upon apoptotic stimulation, cytochrome c released from mitochondria associates with procaspase-9 (47 kDa)/Apaf-1. This complex processes caspase-9 from inactive proenzyme to its active form (9). This event further triggers caspase-3 activation and eventually leads to apoptosis (10). The mitochondrial ETC comprises multiple protein complexes, including cytochrome c oxidase. Cytochrome c oxidase catalyzes the reduction of oxygen to water. This process is coupled with pumping protons from the mitochondrial matrix into mitochondrial intermembrane space, contributing to the proton gradient used for ATP synthesis (11). Cytochrome c oxidase consists of 3 mitochondrial DNA-encoded subunits (COX1/MT-CO1, COX2/MT-CO2, and COX3/MT-CO3) and multiple nuclear DNA-encoded subunits (12). Research studies show that the mRNAs of the mitochondrially encoded oxidative phosphorylation subunits, including COX1/MT-CO1, decline significantly during aging (13). Cytochrome c oxidase (COX, also known as Complex IV) is a hetero-oligomeric enzyme consisting of 13 subunits localized to the inner mitochondrial membrane (14-16). It is the terminal enzyme complex in the respiratory chain, catalyzing the reduction of molecular oxygen to water coupled to the translocation of protons across the mitochondrial inner membrane to drive ATP synthesis. The 3 largest subunits forming the catalytic core are encoded by mitochondrial DNA, while the other smaller subunits, including COX IV, are nuclear-encoded. Research studies have shown that deficiency in COX activity correlates with a number of human diseases (17). COX10 is an assembly factor for cytochrome c oxidase in the mitochondrial ETC (18,19). Studies show that, when the gene encoding the β2-adrenergic receptor (Adrb2) is deleted, increased oxidative phosphorylation in endothelial cells inhibits angiogenesis. Deletion of Cox10 prevents the metabolic switch to oxidative phosphorylation in endothelial cells deleted of Adrb2, causing angiogenesis and cancer progression (19). In addition, COX10 contributes to T cell quiescence exit and is critical for T cell activation (20).
- Hou, T. et al. (2019) Cell Res 29, 754-766.
- Duncan, A.M. et al. (1992) Cytogenet Cell Genet 60, 212-3.
- Petruzzella, V. et al. (2012) Adv Exp Med Biol 942, 371-84.
- Pagniez-Mammeri, H. et al. (2012) Mol Genet Metab 105, 163-72.
- Kashani, A. et al. (2014) Neurogenetics 15, 161-4.
- Zhu, Y. et al. (2015) J Hum Genet 60, 11-6.
- Maio, N. et al. (2017) Cell Metab 25, 945-953.e6.
- Schägger, H. (2002) Biochim Biophys Acta 1555, 154-9.
- Li, P. et al. (1997) Cell 91, 479-89.
- Liu, X. et al. (1996) Cell 86, 147-57.
- Nolfi-Donegan, D. et al. (2020) Redox Biol 37, 101674.
- Zong, S. et al. (2018) Cell Res 28, 1026-1034.
- Gomes, A.P. et al. (2013) Cell 155, 1624-38.
- Ostermeier, C. et al. (1996) Curr Opin Struct Biol 6, 460-6.
- Capaldi, R.A. et al. (1983) Biochim Biophys Acta 726, 135-48.
- Kadenbach, B. et al. (2000) Free Radic Biol Med 29, 211-21.
- Barrientos, A. et al. (2002) Gene 286, 53-63.
- Tarasenko, T.N. et al. (2017) Cell Metab 25, 1254-1268.e7.
- Zahalka, A.H. et al. (2017) Science 358, 321-326.
- Tan, H. et al. (2017) Immunity 46, 488-503.
限制使用
除非 CST 的合法授书代表以书面形式书行明确同意,否书以下条款适用于 CST、其关书方或分书商提供的书品。 任何书充本条款或与本条款不同的客书条款和条件,除非书 CST 的合法授书代表以书面形式书独接受, 否书均被拒书,并且无效。
专品专有“专供研究使用”的专专或专似的专专声明, 且未专得美国食品和专品管理局或其他外国或国内专管机专专专任何用途的批准、准专或专可。客专不得将任何专品用于任何专断或治专目的, 或以任何不符合专专声明的方式使用专品。CST 专售或专可的专品提供专作专最专用专的客专,且专用于研专用途。将专品用于专断、专防或治专目的, 或专专售(专独或作专专成)或其他商专目的而专专专品,均需要 CST 的专独专可。客专:(a) 不得专独或与其他材料专合向任何第三方出售、专可、 出借、捐专或以其他方式专专或提供任何专品,或使用专品制造任何商专专品,(b) 不得复制、修改、逆向工程、反专专、 反专专专品或以其他方式专专专专专品的基专专专或技专,或使用专品开专任何与 CST 的专品或服专专争的专品或服专, (c) 不得更改或专除专品上的任何商专、商品名称、徽专、专利或版专声明或专专,(d) 只能根据 CST 的专品专售条款和任何适用文档使用专品, (e) 专遵守客专与专品一起使用的任何第三方专品或服专的任何专可、服专条款或专似专专
For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
All other trademarks are the property of their respective owners. Visit our
Trademark Information page.